36 related articles for article (PubMed ID: 10215728)
1. Metformin and Micronutrient Status in Type 2 Diabetes: Does Polypharmacy Involving Acid-Suppressing Medications Affect Vitamin B12 Levels?
Wakeman M; Archer DT
Diabetes Metab Syndr Obes; 2020; 13():2093-2108. PubMed ID: 32606868
[TBL] [Abstract][Full Text] [Related]
2. Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.
Mohn ES; Kern HJ; Saltzman E; Mitmesser SH; McKay DL
Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29558445
[TBL] [Abstract][Full Text] [Related]
3. Metformin With Either Histamine H2-Receptor Antagonists or Proton Pump Inhibitors: A Polypharmacy Recipe for Neuropathy via Vitamin B12 Depletion.
Zdilla MJ
Clin Diabetes; 2015 Apr; 33(2):90-5. PubMed ID: 25897192
[No Abstract] [Full Text] [Related]
4. A benefit-risk assessment of the use of proton pump inhibitors in the elderly.
Masclee GM; Sturkenboom MC; Kuipers EJ
Drugs Aging; 2014 Apr; 31(4):263-82. PubMed ID: 24634248
[TBL] [Abstract][Full Text] [Related]
5. Possible interethnic differences in omeprazole pharmacokinetics : comparison of Jordanian Arabs with other populations.
Shilbayeh S; Tutunji MF
Clin Pharmacokinet; 2006; 45(6):593-610. PubMed ID: 16719541
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics in drug regulation: promise, potential and pitfalls.
Shah RR
Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1617-38. PubMed ID: 16096112
[TBL] [Abstract][Full Text] [Related]
7. The use of proton pump inhibitors in children: a comprehensive review.
Gibbons TE; Gold BD
Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of the cytochrome P450 2C19 genetic polymorphism.
Desta Z; Zhao X; Shin JG; Flockhart DA
Clin Pharmacokinet; 2002; 41(12):913-58. PubMed ID: 12222994
[TBL] [Abstract][Full Text] [Related]
9. Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient.
Furuta T; Takashima M; Shirai N; Xiao F; Hanai H; Ohashi K; Ishizaki T
Clin Pharmacol Ther; 2000 Jun; 67(6):684-9. PubMed ID: 10872651
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem.
Klotz U
Int J Clin Pharmacol Ther; 2006 Jul; 44(7):297-302. PubMed ID: 16961157
[TBL] [Abstract][Full Text] [Related]
11. Effect of CYP2C19 polymorphism on serum levels of vitamin B12 in patients on long-term omeprazole treatment.
Sagar M; Janczewska I; Ljungdahl A; Bertilsson L; Seensalu R
Aliment Pharmacol Ther; 1999 Apr; 13(4):453-8. PubMed ID: 10215728
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders.
Sagar M; Bertilsson L; Stridsberg M; Kjellin A; Mârdh S; Seensalu R
Aliment Pharmacol Ther; 2000 Nov; 14(11):1495-502. PubMed ID: 11069321
[TBL] [Abstract][Full Text] [Related]
13. Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism.
Sagar M; Tybring G; Dahl ML; Bertilsson L; Seensalu R
Gastroenterology; 2000 Sep; 119(3):670-6. PubMed ID: 10982760
[TBL] [Abstract][Full Text] [Related]
14. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
[TBL] [Abstract][Full Text] [Related]
15. Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
Meyer UA
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S21-5. PubMed ID: 8930576
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
